Copyright
©2014 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 7, 2014; 20(1): 183-192
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.183
Published online Jan 7, 2014. doi: 10.3748/wjg.v20.i1.183
Figure 5 Kaplan-Meier survival curves of hepatocellular carcinoma patients classified according to hepatitis B virus status.
A and B: In hepatocellular carcinoma (HCC) patients negative for serum hepatitis B virus (HBV) DNA, the overall survival (OS) (A) and progression-free survival (PFS) (B) of HCC patients with anaplastic lymphoma kinase copy number gain (ALK/CNG)-positivity and ALK/CNG-negativity; C and D: The OS (C) and PFS (D) in HCC patients positive for serum HBV DNA.
-
Citation: Jia SW, Fu S, Wang F, Shao Q, Huang HB, Shao JY.
ALK gene copy number gain and its clinical significance in hepatocellular carcinoma. World J Gastroenterol 2014; 20(1): 183-192 - URL: https://www.wjgnet.com/1007-9327/full/v20/i1/183.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i1.183